Results 241 to 250 of about 219,574 (288)
Some of the next articles are maybe not open access.
AI/ML Models to Predict the Severity of Drug-Induced Liver Injury for Small Molecules.
Chemical Research in Toxicology, 2023Drug-induced liver injury (DILI), believed to be a multifactorial toxicity, has been a leading cause of attrition of small molecules during discovery, clinical development, and postmarketing.
Mohan Rao +9 more
semanticscholar +1 more source
Pharmacology & Toxicology, 1992
Abstract:We examined the possibility of predicting the extent of hepatic drug‐oxidizing capacity by determination of caffeine, trimethadione and their metabolites in three groups of rats with chemically induced liver injuries. Trimethadione (4 mg/kg) and caffeine (10 mg/kg) were simultaneously administered as two probe drugs.
E, Tanaka, A, Ishikawa, S, Misawa
openaire +2 more sources
Abstract:We examined the possibility of predicting the extent of hepatic drug‐oxidizing capacity by determination of caffeine, trimethadione and their metabolites in three groups of rats with chemically induced liver injuries. Trimethadione (4 mg/kg) and caffeine (10 mg/kg) were simultaneously administered as two probe drugs.
E, Tanaka, A, Ishikawa, S, Misawa
openaire +2 more sources
Phytotherapy Research, 2023
Drug‐induced liver injury (DILI) refers to adverse reactions to small chemical compounds, biological agents, and medical products. These reactions can manifest as acute or chronic damage to the liver.
Deepti Singh +2 more
semanticscholar +1 more source
Drug‐induced liver injury (DILI) refers to adverse reactions to small chemical compounds, biological agents, and medical products. These reactions can manifest as acute or chronic damage to the liver.
Deepti Singh +2 more
semanticscholar +1 more source
Chemical probes for drug-induced liver injury imaging.
Future Medicinal Chemistry, 2020Drug-induced liver injury (DILI) has been a long-standing concern of modern medicine, and the single most frequent reason for drug nonapprovals and postapproval restrictions or withdrawals.
Tao Jiang, Pengfei Rong, Wei Wang
semanticscholar +1 more source
Journal of Chemical Information and Modeling
Drug-induced liver injury (DILI) is a major challenge in drug development, often leading to clinical trial failures and market withdrawals due to liver toxicity.
Jiahui Guan +7 more
semanticscholar +1 more source
Drug-induced liver injury (DILI) is a major challenge in drug development, often leading to clinical trial failures and market withdrawals due to liver toxicity.
Jiahui Guan +7 more
semanticscholar +1 more source
TCN-RDP: Predicting Drug-Induced Liver Injury from Time-Series Toxicogenomic Data
Journal of Chemical Information and ModelingDrug-induced liver injury (DILI) is a major obstacle in drug development, often leading to high failure rates in clinical trials. Traditional toxicological assessments are slow and resource-intensive, making early prediction of hepatotoxicity a ...
Zhongyan Zhao +9 more
semanticscholar +1 more source
Vanishing bile duct syndrome in drug-induced liver injury: clinical and pathologic perspectives
Exploration of MedicineVanishing bile duct syndrome (VBDS) is a rare condition, representing approximately 0.5% of small bile duct diseases, characterized by progressive destruction of intrahepatic bile ducts, leading to ductopenia.
Sugunah Sallapan +4 more
semanticscholar +1 more source
Journal of Cheminformatics
Drug-induced liver injury (DILI) is a significant concern in drug development, often leading to the discontinuation of clinical trials and the withdrawal of drugs from the market.
Taeyeub Lee, J. Posma
semanticscholar +1 more source
Drug-induced liver injury (DILI) is a significant concern in drug development, often leading to the discontinuation of clinical trials and the withdrawal of drugs from the market.
Taeyeub Lee, J. Posma
semanticscholar +1 more source
Journal of Applied Toxicology, 2013
ABSTRACTDrug‐induced liver injury (DILI) is a major adverse drug reaction that accounts for one‐third of post‐marketing drug withdrawals. Several classifiers for human hepatotoxicity using chemical descriptors with limited prediction accuracies have been published.
Xiang-Wei, Zhu +2 more
openaire +2 more sources
ABSTRACTDrug‐induced liver injury (DILI) is a major adverse drug reaction that accounts for one‐third of post‐marketing drug withdrawals. Several classifiers for human hepatotoxicity using chemical descriptors with limited prediction accuracies have been published.
Xiang-Wei, Zhu +2 more
openaire +2 more sources
2025 2nd International Conference on New Frontiers in Communication, Automation, Management and Security (ICCAMS)
This research aims to create a drug-induced liver injury (DILI) severity prediction system based on machine learning to aid healthcare professionals in safety assessment.
Vyshali J. Gogi +2 more
semanticscholar +1 more source
This research aims to create a drug-induced liver injury (DILI) severity prediction system based on machine learning to aid healthcare professionals in safety assessment.
Vyshali J. Gogi +2 more
semanticscholar +1 more source

